UA94211C2 - Isolated fully human monoclonal anti-cd3 antibody - Google Patents
Isolated fully human monoclonal anti-cd3 antibodyInfo
- Publication number
- UA94211C2 UA94211C2 UAA200700106A UAA200700106A UA94211C2 UA 94211 C2 UA94211 C2 UA 94211C2 UA A200700106 A UAA200700106 A UA A200700106A UA A200700106 A UAA200700106 A UA A200700106A UA 94211 C2 UA94211 C2 UA 94211C2
- Authority
- UA
- Ukraine
- Prior art keywords
- human monoclonal
- fully human
- antibody
- monoclonal anti
- isolated fully
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention relates to fully human monoclonal antibody directed to CD3 or immunologically active fragment thereof.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57648304P | 2004-06-03 | 2004-06-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA94211C2 true UA94211C2 (en) | 2011-04-26 |
Family
ID=38166712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200700106A UA94211C2 (en) | 2004-06-03 | 2005-06-03 | Isolated fully human monoclonal anti-cd3 antibody |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN1984931B (en) |
UA (1) | UA94211C2 (en) |
ZA (1) | ZA200609891B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2647707T3 (en) * | 2010-11-30 | 2019-02-28 | Chugai Seiyaku Kabushiki Kaisha | Cytotoxicity-inducing therapeutic agent |
SG10201705787VA (en) * | 2012-09-27 | 2017-08-30 | Merus Nv | BISPECIFIC IgG ANTIBODIES AS T CELL ENGAGERS |
CN111410691B (en) * | 2014-03-28 | 2024-02-13 | Xencor公司 | Bispecific antibodies that bind to CD38 and CD3 |
HUE059417T2 (en) * | 2014-11-24 | 2022-11-28 | Regeneron Pharma | Non-human animals expressing humanized cd3 complex |
CN104558180B (en) * | 2014-12-31 | 2017-11-03 | 四川大学 | Target the human single chain variable fragments antibody of T lymphocytes |
TWI726862B (en) * | 2015-01-23 | 2021-05-11 | 法商賽諾菲公司 | Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123 |
SI3115376T1 (en) | 2015-07-10 | 2018-12-31 | Merus N.V. | Human cd3 binding antibody |
SG11202010580TA (en) * | 2018-05-23 | 2020-12-30 | Pfizer | Antibodies specific for cd3 and uses thereof |
CN115536740A (en) * | 2021-06-30 | 2022-12-30 | 苏州方德门达新药开发有限公司 | Space conformation epitope for effectively retaining CD3 in mediated cell and application thereof |
WO2023169419A1 (en) * | 2022-03-09 | 2023-09-14 | Antengene (Hangzhou) Biologics Co., Ltd. | Novel anti-cd3 antibodies and uses thereof |
CN115850486B (en) * | 2022-11-16 | 2023-05-30 | 艾可泰科(浙江)控股有限公司 | Use of islet stem cells in the treatment of diabetes |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1169953C (en) * | 1999-11-30 | 2004-10-06 | 中国医学科学院中国协和医科大学血液学研究所血液病医院 | CD3-resisting single clone antibody heavy-chain and light-chain variable-area gene and its application |
CN1189483C (en) * | 2001-11-23 | 2005-02-16 | 上海中信国健药业有限公司 | Humanized CD3-resisting monoclonal antibody |
-
2005
- 2005-06-03 UA UAA200700106A patent/UA94211C2/en unknown
- 2005-06-03 CN CN2005800234997A patent/CN1984931B/en active Active
-
2006
- 2006-11-27 ZA ZA200609891A patent/ZA200609891B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1984931A (en) | 2007-06-20 |
ZA200609891B (en) | 2008-07-30 |
CN1984931B (en) | 2012-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA94211C2 (en) | Isolated fully human monoclonal anti-cd3 antibody | |
IL244803B (en) | Humanized anti-beta7 antibodies and uses therefor | |
ZA200501054B (en) | Transplant acceptance inducing cells of monocytic origin and their preparation and use. | |
WO2003100033A3 (en) | ANTI-αvβ6 ANTIBODIES | |
TW200639182A (en) | Antibody variants and uses thereof | |
UA92505C2 (en) | Anti-cd3 antibody formulations | |
IL179672A (en) | Human monoclonal anti-cd3 antibodies | |
NZ605429A (en) | Therapeutic human anti-il-1r1 monoclonal antibody | |
CY1111622T1 (en) | ANTI-CMET HUMANIZED COMPETITORS | |
HK1098825A1 (en) | Human monoclonal antibodies against cd20 | |
TW200510459A (en) | RG1 antibodies and uses thereof | |
HK1077226A1 (en) | Human monoclonal antibodies against cd25 | |
TW200603828A (en) | Treatment of disorders | |
ITMI20031127A1 (en) | ANTI-HGF-R ANTIBODIES AND THEIR USE | |
WO2006029220A3 (en) | Combination therapy with anti-ctla4 and anti-4-1bb antibodies | |
UA98100C2 (en) | Humanized monoclonal antibody that binds and neutralizes human nogo | |
UA96426C2 (en) | Isolated human or humanized antibody that specifically binds to il-13 |